Casirivimab and Imdevimab (REGEN-COV)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Casirivimab and Imdevimab (REGEN-COV), covering 2023-02-21 to 2024-08-20. Get the full timeline:
Most recent: Clinical Trial Update: COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers [Phase 2]